Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$12.22 - $15.79 $373,932 - $483,174
-30,600 Closed
0 $0
Q4 2020

Feb 02, 2021

SELL
$11.65 - $22.07 $31,385 - $59,456
-2,694 Reduced 8.09%
30,600 $593,000
Q3 2020

Nov 05, 2020

BUY
$8.96 - $14.12 $37,578 - $59,219
4,194 Added 14.41%
33,294 $372,000
Q2 2020

Aug 12, 2020

BUY
$7.27 - $14.18 $211,557 - $412,638
29,100 New
29,100 $394,000
Q2 2018

Aug 15, 2018

SELL
$10.41 - $17.85 $260,250 - $446,250
-25,000 Closed
0 $0
Q4 2017

Feb 06, 2018

BUY
$10.43 - $14.75 $260,750 - $368,750
25,000
25,000 $294,000

Others Institutions Holding SPRO

About Spero Therapeutics, Inc.


  • Ticker SPRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,067,500
  • Market Cap $27M
  • Description
  • Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to ...
More about SPRO
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.